Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Nezi

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaKarla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature|February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancerGiannicola Genovese, Alessandro Carugo, James Tepper, et al.
NPJ Genomic Medicine|August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Nature Medicine|November 18, 2021
Reporting guidelines for human microbiome research: the STORMS checklistChloe Mirzayi, Audrey Renson, , et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaKarla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature|February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancerGiannicola Genovese, Alessandro Carugo, James Tepper, et al.
NPJ Genomic Medicine|August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Nature Medicine|November 18, 2021
Reporting guidelines for human microbiome research: the STORMS checklistChloe Mirzayi, Audrey Renson, , et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 5